The Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In Situ in Patients with Intraductal Papilloma without Atypia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 034)-Reference-Cited by-同舟云学术

The Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In Situ in Patients with Intraductal Papilloma without Atypia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 034)

Published:2020-10-12 Issue:5 Volume:28 Page:2573-2578
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Nakhlis Faina,Baker Gabrielle M.,Pilewskie Melissa,Gelman Rebecca,Calvillo Katherina Z.,Ludwig Kandice,McAuliffe Priscilla F.,Willey Shawna,Rosenberger Laura H.,Parker Catherine,Gallagher Kristalyn,Jacobs Lisa,Feldman Sheldon,Lange Paulina,DeSantis Stephen D.,Schnitt Stuart J.,King Tari A.

Funder

Susan G. Komen

Breast Cancer Research Foundation

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

https://link.springer.com/content/pdf/10.1245/s10434-020-09215-w.pdf

Reference31 articles.

1. Bekes I, deGregorio A, deWaal A, et al. Review on current treatment options for lesions of uncertain malignant potential (B3 lesions) of the breast: Do B3 papillary lesions need to be removed in any case by open surgery? Arch Gynecol Obstet. 2019;300:481–4.

2. Neal L, Sandhu NP, Hieken TJ, et al. Diagnosis and management of benign, atypical, and indeterminate breast lesions detected on core needle biopsy. Mayo Clin Proc. 2014;89:536–47.